These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24502931)

  • 1. Experts call for research into vCJD test despite only 70% accuracy.
    O'Dowd A
    BMJ; 2014 Feb; 348():g1415. PubMed ID: 24502931
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus conference on vCJD screening of blood donors: report of the panel.
    McCullough J; Anderson D; Brookie D; Bouchard JP; Fergusson D; Joly J; Kenny N; Lee D; Megânn H; Page D; Reinharz D; Williams JR; Wilson K
    Transfusion; 2004 May; 44(5):675-83. PubMed ID: 15104647
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets.
    Cooper JK; Ladhani K; Minor P
    Vox Sang; 2012 Feb; 102(2):100-9. PubMed ID: 22126309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly specific blood test for vCJD.
    Jackson GS; Burk-Rafel J; Edgeworth JA; Sicilia A; Abdilahi S; Korteweg J; Mackey J; Thomas C; Wang G; Mead S; Collinge J
    Blood; 2014 Jan; 123(3):452-3. PubMed ID: 24434999
    [No Abstract]   [Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
    Sandler SG
    Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456
    [No Abstract]   [Full Text] [Related]  

  • 6. Scientists race to develop a blood test for vCJD.
    Nat Med; 2001 Mar; 7(3):261. PubMed ID: 11231599
    [No Abstract]   [Full Text] [Related]  

  • 7. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.
    Fagge T; Barclay GR; Macgregor I; Head M; Ironside J; Turner M
    Transfusion; 2005 Apr; 45(4):504-13. PubMed ID: 15819670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards a blood test for vCJD?
    Anstee DJ
    Vox Sang; 2002 Aug; 83 Suppl 1():203-5. PubMed ID: 12617138
    [No Abstract]   [Full Text] [Related]  

  • 9. Political barriers are hampering efforts to develop vCJD screening tools, MPs are told.
    O'Dowd A
    BMJ; 2014 Mar; 348():g2001. PubMed ID: 24609923
    [No Abstract]   [Full Text] [Related]  

  • 10. A prototype assay to detect vCJD-infected blood.
    Gregori L
    Lancet; 2011 Feb; 377(9764):444-6. PubMed ID: 21295340
    [No Abstract]   [Full Text] [Related]  

  • 11. Should MRI signs be included in the diagnostic criteria for sporadic Creutzfeldt-Jakob disease?
    Zanusso G
    Nat Clin Pract Neurol; 2006 Feb; 2(2):68-9. PubMed ID: 16932524
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of vCJD on blood supply.
    Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
    Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
    Brown P; Cervenáková L; Diringer H
    J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
    Gregori L; Yang H; Anderson S
    Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood test for variant Creutzfeldt-Jakob disease.
    Bennett P
    JAMA Neurol; 2014 Aug; 71(8):1054. PubMed ID: 25111210
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
    Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
    Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the diagnostic tools.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 20. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
    Minor PD
    Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.